A protein phosphatase 1 specific

phosphatase targeting peptide (PhosTAP) phosphoprotein phosphatases (PPP) protein engineering protein phosphatase 1 (PP1) protein–protein interactions

Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
29 Oct 2024
Historique:
medline: 24 10 2024
pubmed: 24 10 2024
entrez: 24 10 2024
Statut: ppublish

Résumé

Phosphoprotein phosphatases (PPPs) are the key serine/threonine phosphatases that regulate all essential signaling cascades. In particular, Protein Phosphatase 1 (PP1) dephosphorylates ~80% of all ser/thr phosphorylation sites. Here, we developed a phosphatase targeting peptide (PhosTAP) that binds all PP1 isoforms and does so with a stronger affinity than any other known PP1 regulator. This PhosTAP can be used as a PP1 recruitment tool for Phosphorylation Targeting Chimera (PhosTAC)-type recruitment in in vitro and cellular experiments, as well as in phosphoproteomics experiments to identify PP1-specific substrates and phosphosites. The latter is especially important to further our understanding of cellular signaling, as the identification of substrates and especially phosphosites that are targeted by specific phosphatases lags behind that of their kinase counterparts. Using PhosTAP-based proteomics, we show that, counter to our current understanding, many PP1 regulators are also substrates, that the number of residues between regulator PP1-binding and phosphosites vary significantly, and that PP1 counteracts the activities of mitotic kinases. Finally, we also found that Haspin kinase is a direct substrate of PP1 and that its PP1-dependent dephosphorylation modulates its activity during anaphase. Together, we show that PP1-specific PhosTAPs are a powerful tool for +studying PP1 activity in vitro and in cells.

Identifiants

pubmed: 39446389
doi: 10.1073/pnas.2415383121
doi:

Substances chimiques

Protein Phosphatase 1 EC 3.1.3.16
Peptides 0
Phosphoproteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2415383121

Subventions

Organisme : HHS | NIH | National Institute of General Medical Sciences (NIGMS)
ID : R01GM144379
Organisme : HHS | NIH | National Institute of General Medical Sciences (NIGMS)
ID : R35GM119455
Organisme : HHS | NIH | National Institute of General Medical Sciences (NIGMS)
ID : R01GM134683
Organisme : HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS)
ID : R01NS124666

Déclaration de conflit d'intérêts

Competing interests statement:The authors declare no competing interest.

Auteurs

Meng S Choy (MS)

Department of Molecular Biology and Biophysics, UConn Health, Farmington, CT 06030.

Hieu T Nguyen (HT)

Department of Biochemistry and Cell Biology, Geisel School of Medicine at Dartmouth, Hanover, NH 03755.

Ganesan S Kumar (GS)

Department of Molecular Biology and Biophysics, UConn Health, Farmington, CT 06030.
National Institute of Immunology, New Delhi 110067, India.

Wolfgang Peti (W)

Department of Molecular Biology and Biophysics, UConn Health, Farmington, CT 06030.

Arminja N Kettenbach (AN)

Department of Biochemistry and Cell Biology, Geisel School of Medicine at Dartmouth, Hanover, NH 03755.
Dartmouth Cancer Center, Lebanon, NH 03756.

Rebecca Page (R)

Department of Cell Biology, UConn Health, Farmington, CT 06030.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH